Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine nasal spray for ophthalmic neuralgia in relapsing-remitting multiple sclerosis
IRCT20231029059896N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of lidocaine in trigeminal neuralgia (TN), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Pain intensity, Pain-free time after each use and 4 more. Started Oct 2023; status: completed.
02
Drugs
lidocaine
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on IRCT20231029059896N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231029059896N1.